Vapocoolant Spray Application During Intraarticular Knee Injection

NCT05581433 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 150

Last updated 2022-10-21

No results posted yet for this study

Summary

The goal of this observational study is to learn about the effects of vapocoolant spray applied during intraarticular knee injections on pain and anxiety compared to injections without any agent application in patients with knee osteoarthritis.

The main questions it aims to answer are: • Contrary to popular belief, does coolant spray application really reduce pain? • Does it have an advantage over patients with placebo or no spray at all? After intraarticular knee hyaluronic acid application, patients will be asked to indicate injection-related pain and anxiety levels on a 100mm visual analog scale. Researchers will compare the patient groups who were applied coolant spray, placebo spray and injection without any spray.

Conditions

  • Osteo Arthritis Knee
  • Injection Site Discomfort
  • Injection Fear

Interventions

OTHER

Topical Cooling Spray

The process of cooling the area to be injected with a cooling spray before the application in order to reduce the pain.

OTHER

Saline spray as Placebo

Application of saline spray without cooling effect to the area to be injected for placebo purposes

Sponsors & Collaborators

  • Istanbul Rumeli University

    lead OTHER

Principal Investigators

  • Çağdaş Pamuk, MD · Istanbul Rumeli University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-10-20
Primary Completion
2022-10-20
Completion
2023-01-30

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05581433 on ClinicalTrials.gov